SEARCH:   Advanced

Erratum for Ratzinger et al., Blood 101 (4) 1422-1429. Blood, 15 April 2005, Vol. 105, No. 8, pp. 3018. This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  ERRATUM In the article by Ratzinger et al entitled "Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation," which appeared in the February 15, 2003, issue of Blood (Volume 101:1422-1429), there was an incorrect dosage in the third paragraph under "Cell purification and generation of DCs." The correct dosage of FLT-3 ligand is 50 ng/mL. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                   What's this?

	Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020